Second, we didn't include patients with obstructive lung disorders (such as COPD or asthma) since bronchoscopic exams with sample samplings are admitted only if clinically justified, such as exacerbations, which may also alter KL‐6 assessment and not be feasible for the aims of the study. This evidence concerns the gene MUC1 and asthma.